paraquat has been researched along with oxidopamine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 18 (66.67) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, ZH; Niki, E; Saito, Y; Yoshida, Y | 1 |
| Bové, J; Perier, C; Prou, D; Przedborski, S | 1 |
| Kordower, JH; O'Malley, J; Soderstrom, K; Steece-Collier, K | 1 |
| James-Kracke, M; Miller, RL; Sun, AY; Sun, GY | 1 |
| Cannon, JR; Greenamyre, JT | 1 |
| Bové, J; Perier, C | 1 |
| Tieu, K | 1 |
| Armentero, MT; Blandini, F | 1 |
| Dranka, BP; Kalyanaraman, B; Kanthasamy, AG; Zielonka, J | 1 |
| Ding, M; Li, F; Pang, H; Tian, X; Wang, B; Zhou, Y; Zhu, L | 1 |
| Day, BJ; Lopert, P; Patel, M | 1 |
| Anandhan, A; Burns, M; Chen, H; Franco, R; Garcia-Garcia, A; Zhou, Y | 1 |
| Dagda, RK; Das Banerjee, T; Janda, E | 1 |
| Armstrong, SM; Moore, C; Willis, GL | 1 |
| Dodds, ED; Franco, R; Garcia-Garcia, A; Huang, Y; Lei, S; Madayiputhiya, N; Nandakumar, R; Powers, R; Stanton, RC; Zavala-Flores, L | 1 |
| Arrant, AE; Bodhicharla, RK; Cyr, DD; González-Hunt, CP; Hammarlund, M; Kosmaczewski, SG; Leung, MC; Margillo, KM; McKeever, MG; Meyer, JN; Ryde, IT | 1 |
| Morrison, BE; Stojkovska, I; Wagner, BM | 1 |
| Dikalova, YV; Khudoerkov, RM; Sheloukhova, LI; Voronkov, DN | 1 |
| Gartner, A; Jongsma, E; Offenburger, SL | 1 |
| Coakley, S; Gartner, A; Hilliard, MA; Ho, XY; Offenburger, SL; Tachie-Menson, T | 1 |
| Ivanets, EV; Menchinskaya, ES; Pislyagin, EA; Smetanina, OF; Trinh, PTH; Yurchenko, AN; Yurchenko, EA | 1 |
| Freeman, JL; Wasel, O | 1 |
| Buechner, S; Dassati, S; Schweigreiter, R; Waldner, A | 1 |
| Baetu, I; Collins-Praino, LE; El-Gamal, M; Fathalla, AM; Mohamed, W; Moustafa, AA; Salama, M; Soliman, AM | 1 |
| Aminin, D; Chingizova, E; Likhatskaya, G; Menchinskaya, E; Pelageev, D; Pislyagin, E; Polonik, S; Sabutski, Y | 1 |
| Bernardino, L; Cristóvão, AC; Esteves, M; Ferreira, R; Lopes-Nunes, J; Santos, T; Saraiva, C; Vale, A | 1 |
11 review(s) available for paraquat and oxidopamine
| Article | Year |
|---|---|
Toxin-induced models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Herbicides; Humans; Neurotoxins; Oxidative Stress; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Rotenone; Sympatholytics | 2005 |
Neural repair strategies for Parkinson's disease: insights from primate models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Transplantation; Deep Brain Stimulation; Disease Models, Animal; Fungicides, Industrial; Glial Cell Line-Derived Neurotrophic Factor; Herbicides; Humans; Maneb; Nerve Degeneration; Oxidopamine; Paraquat; Parkinson Disease; Pesticides; Primates; Rotenone | 2006 |
Oxidative and inflammatory pathways in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Herbicides; Humans; Inflammation; Lipopolysaccharides; Microglia; Mitogen-Activated Protein Kinases; NADPH Oxidases; Neurotoxins; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Paraquat; Parkinson Disease; Parkinsonian Disorders; Protein Kinase C; Rotenone | 2009 |
Neurotoxic in vivo models of Parkinson's disease recent advances.
Topics: Animals; Disease Models, Animal; Dopamine; Humans; MPTP Poisoning; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Rotenone; Sympatholytics; Uncoupling Agents | 2010 |
Neurotoxin-based models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Death; Disease Models, Animal; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Rotenone | 2012 |
A guide to neurotoxic animal models of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Haplorhini; Lewy Bodies; Mice; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rotenone; Substantia Nigra | 2011 |
Animal models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Animals, Genetically Modified; Disease Models, Animal; Dopamine Agents; Herbicides; Humans; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Sympatholytics | 2012 |
How Parkinsonian toxins dysregulate the autophagy machinery.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Autophagy; Humans; Methamphetamine; Mitophagy; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rotenone | 2013 |
Parkinson's disease and enhanced inflammatory response.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Inflammation; Lipopolysaccharides; Neurons; Oxidative Stress; Oxidopamine; Oxygen; Paraquat; Parkinson Disease; Ubiquitin-Protein Ligases | 2015 |
Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Gene Knockdown Techniques; Neurotoxicity Syndromes; Oxidopamine; Paraquat; Parkinson Disease; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Rotenone; Zebrafish; Zebrafish Proteins | 2020 |
Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Humans; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rodentia; Substantia Nigra | 2021 |
16 other study(ies) available for paraquat and oxidopamine
| Article | Year |
|---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage.
Topics: Adaptation, Physiological; Adrenergic Agents; Animals; Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Herbicides; Hydrogen Peroxide; L-Lactate Dehydrogenase; Oxidative Stress; Oxidopamine; Paraquat; PC12 Cells; Rats; Time Factors | 2005 |
Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Adrenergic Agents; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Line, Transformed; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Energy Metabolism; Herbicides; Insecticides; Neurotoxins; Oligomycins; Oxidopamine; Oxygen Consumption; Paraquat; Proton Ionophores; Rats; Rotenone; Superoxides; Time Factors | 2012 |
Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 3; Caspase 7; Caspase Inhibitors; Cell Line, Tumor; Chromogranins; Dopamine; Dopaminergic Neurons; Down-Regulation; HEK293 Cells; Humans; Nerve Tissue Proteins; Neuroblastoma; Neurotoxins; Oxidopamine; Paraquat; Recombinant Fusion Proteins; RNA, Messenger; Substrate Specificity | 2012 |
Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells.
Topics: Animals; Auranofin; Cell Death; Cell Line; Cell Respiration; Dopaminergic Neurons; Drug Synergism; Energy Metabolism; Enzyme Inhibitors; Gene Knockdown Techniques; Hydrogen Peroxide; Lentivirus; Mesencephalon; Mitochondria; Oxidative Stress; Oxidopamine; Paraquat; Peroxiredoxins; Rats; RNA, Messenger; RNA, Small Interfering; Thioredoxin Reductase 2 | 2012 |
Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicity.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Autophagy-Related Protein 5; Caspase 3; Caspase Inhibitors; Cathepsins; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Humans; Microtubule-Associated Proteins; Neurons; Oxidopamine; Paraquat; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Rotenone; Signal Transduction; TOR Serine-Threonine Kinases; Transfection | 2013 |
Parkinson's disease, lights and melanocytes: looking beyond the retina.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Female; Light; Male; Melanocytes; Motor Activity; Oxidopamine; Paraquat; Parkinson Disease; Rats; Rats, Sprague-Dawley; Retina; Rotenone | 2014 |
Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity.
Topics: 1-Methyl-4-phenylpyridinium; Cell Death; Cell Line, Tumor; Dopamine; Energy Metabolism; Environmental Pollutants; Female; Glucosephosphate Dehydrogenase; Glycolysis; Herbicides; Humans; Magnetic Resonance Spectroscopy; Metabolome; Mitochondria; Oxidation-Reduction; Oxidopamine; Paraquat; Pentose Phosphate Pathway; Rotenone; Spectrometry, Mass, Electrospray Ionization | 2014 |
Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans.
Topics: Adrenergic Agents; Animals; Caenorhabditis elegans; DNA Damage; DNA, Mitochondrial; Dopamine; Dopamine Agents; Dopaminergic Neurons; Mitochondria; Mutagens; Nerve Degeneration; Oxidopamine; Paraquat | 2014 |
Quantitative Evaluation of Changes in the Striatal Astrocyte Axons in Simulated Parkinsonism.
Topics: Animals; Astrocytes; Axons; Corpus Striatum; Glial Fibrillary Acidic Protein; Male; Oxidopamine; Paraquat; Parkinsonian Disorders; Rats; Rats, Wistar; Rotenone | 2016 |
Mutations in Caenorhabditis elegans neuroligin-like glit-1, the apoptosis pathway and the calcium chaperone crt-1 increase dopaminergic neurodegeneration after 6-OHDA treatment.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium; Calreticulin; Dopaminergic Neurons; Hydrogen Peroxide; Membrane Proteins; Molecular Chaperones; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Oxidants; Oxidative Stress; Oxidopamine; Paraquat | 2018 |
6-OHDA-induced dopaminergic neurodegeneration in Caenorhabditis elegans is promoted by the engulfment pathway and inhibited by the transthyretin-related protein TTR-33.
Topics: Animals; Animals, Genetically Modified; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carrier Proteins; Dopaminergic Neurons; Hydrogen Peroxide; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mutation; Nerve Degeneration; Oxidants; Oxidative Stress; Oxidopamine; Paraquat; Signal Transduction | 2018 |
Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson's Disease Models.
Topics: Alkaloids; Animals; Antioxidants; Antiparkinson Agents; Aquatic Organisms; Aspergillus; Biological Products; Cell Line, Tumor; Cell Survival; Melatonin; Mice; Neuroprotective Agents; Oxidopamine; Paraquat; Parkinsonian Disorders; Penicillium; Polyketides; Reactive Oxygen Species | 2018 |
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
Topics: Apolipoproteins D; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Celecoxib; Cell Line, Tumor; Hippocampus; Humans; Neuroprotection; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Up-Regulation | 2021 |
Neuroprotective Effect of 1,4-Naphthoquinones in an
Topics: Animals; Biphenyl Compounds; Cell Cycle; Cell Line; Cell Survival; Free Radical Scavengers; Membrane Potential, Mitochondrial; Mice; Models, Biological; Naphthoquinones; Neuroprotection; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Oxidopamine; Paraquat; Picrates; Quantitative Structure-Activity Relationship; Reactive Oxygen Species; Reproducibility of Results | 2021 |
CtBP Neuroprotective Role in Toxin-Based Parkinson's Disease Models: From Expression Pattern to Dopaminergic Survival.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Paraquat; Parkinson Disease; Rats; Substantia Nigra; Transcription Factors | 2023 |